Atlas Trials

R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia

Clinical trial NCT03697356 · UNKNOWN

Trial details

NCT number
NCT03697356
Sponsor
Kosin University Gospel Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Waldenström's Macroglobulinemia
Start date
2019-03-06
Primary completion
2026-05-31
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.